Skip to content
Open access

Integrated Multi-Omics and Experimental Validation Identify a Spermidine-Responsive FREM1 Remodeling Program in Ischemic Heart Failure

Nov 2026 · International Journal of Molecular Sciences · 0 citations · 42 references

Abstract

Ischemic injury drives a sustained myocardial response in which metabolic stress, fibroblast activation, and extracellular-matrix remodeling converge to cause heart failure, yet the cell-resolved programs linking polyamine homeostasis to post-ischemic remodeling and the response to spermidine remain unclear. In this study, we integrated disease-burden estimates with bulk and single-nucleus myocardial transcriptomics, prioritizing polyamine-related genes by differential-expression analysis, gene-set scoring, and machine learning, followed by pathway, immune, cell–cell communication, and regulatory-network analyses, and evaluated spermidine in a post-myocardial-infarction mouse model using 8-week-old male C57BL/6J mice, with fibroblast-directed FREM1 activation to test whether FREM1 modifies the treatment response. Cross-platform analysis identified FREM1, MYH6, ARRDC3, and XAF1 as reproducible components of the ischemic-failing-heart signature, with FREM1 showing the strongest discrimination in the independent cohort; the program localized predominantly to fibroblasts and was linked to extracellular-matrix, inflammatory, and intercellular-signaling states. In mice, spermidine improved systolic function, reduced collagen deposition, shifted MTA and ornithine signals toward the sham pattern, and lowered myocardial FREM1; FREM1 activation weakened these effects, though residual benefit remained. These findings identify a fibroblast-enriched, spermidine-responsive FREM1 remodeling program linking polyamine-associated stress to post-ischemic fibrosis, positioning FREM1 as a candidate regulator of the cardiac response to spermidine and a potential entry point for therapeutic stratification in ischemic heart failure.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.